Skip to content

Quest Diagnostics

NYSE: DGX · USD

Quest Diagnostics financials

6 charts

Revenue

USD millions

$3,043M
Quest Diagnostics Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2009 Q2$1,901.818M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$1,897.146M; −0.2% vs FY 2009 Q2
FY 2009 Q4$1,848.273M; −2.6% vs FY 2009 Q3
FY 2010 Q1$1,805.503M; −2.3% vs FY 2009 Q4
FY 2010 Q2$1,874.727M; +3.8% vs FY 2010 Q1
FY 2010 Q3$1,864.655M; −0.5% vs FY 2010 Q2
FY 2010 Q4$1,824.04M; −2.2% vs FY 2010 Q3
FY 2011 Q1$1,821.577M; −0.1% vs FY 2010 Q4
FY 2011 Q2$1,903.201M; +4.5% vs FY 2011 Q1
FY 2011 Q3$1,906.405M; +0.2% vs FY 2011 Q2
FY 2011 Q4$1,879.307M; −1.4% vs FY 2011 Q3
FY 2012 Q1$1,936.456M; +3.0% vs FY 2011 Q4
FY 2012 Q2$1,906.81M; −1.5% vs FY 2012 Q1
FY 2012 Q3$1,851.439M; −2.9% vs FY 2012 Q2
FY 2012 Q4$1,773.765M; −4.2% vs FY 2012 Q3
FY 2013 Q1$1,786.647M; +0.7% vs FY 2012 Q4
FY 2013 Q2$1,815.74M; +1.6% vs FY 2013 Q1
FY 2013 Q3$1,787.14M; −1.6% vs FY 2013 Q2
FY 2013 Q4$1,756M; −1.7% vs FY 2013 Q3
FY 2014 Q1$1,746M; −0.6% vs FY 2013 Q4
FY 2014 Q2$1,902M; +8.9% vs FY 2014 Q1
FY 2014 Q3$1,904M; +0.1% vs FY 2014 Q2
FY 2014 Q4$1,883M; −1.1% vs FY 2014 Q3
FY 2015 Q1$1,839M; −2.3% vs FY 2014 Q4
FY 2015 Q2$1,925M; +4.7% vs FY 2015 Q1
FY 2015 Q3$1,880M; −2.3% vs FY 2015 Q2
FY 2015 Q4$1,849M; −1.6% vs FY 2015 Q3
FY 2016 Q1$1,863M; +0.8% vs FY 2015 Q4
FY 2016 Q2$1,906M; +2.3% vs FY 2016 Q1
FY 2016 Q3$1,885M; −1.1% vs FY 2016 Q2
FY 2016 Q4$1,861M; −1.3% vs FY 2016 Q3
FY 2017 Q1$1,899M; +2.0% vs FY 2016 Q4
FY 2017 Q2$1,943M; +2.3% vs FY 2017 Q1
FY 2017 Q3$1,931M; −0.6% vs FY 2017 Q2
FY 2017 Q4$1,936M; +0.3% vs FY 2017 Q3
FY 2018 Q1$1,884M; −2.7% vs FY 2017 Q4
FY 2018 Q2$1,919M; +1.9% vs FY 2018 Q1
FY 2018 Q3$1,889M; −1.6% vs FY 2018 Q2
FY 2018 Q4$1,839M; −2.6% vs FY 2018 Q3
FY 2019 Q1$1,891M; +2.8% vs FY 2018 Q4
FY 2019 Q2$1,953M; +3.3% vs FY 2019 Q1
FY 2019 Q3$1,956M; +0.2% vs FY 2019 Q2
FY 2019 Q4$1,926M; −1.5% vs FY 2019 Q3
FY 2020 Q1$1,822M; −5.4% vs FY 2019 Q4
FY 2020 Q2$1,827M; +0.3% vs FY 2020 Q1
FY 2020 Q3$2,786M; +52.5% vs FY 2020 Q2
FY 2020 Q4$3,002M; +7.8% vs FY 2020 Q3
FY 2021 Q1$2,720M; −9.4% vs FY 2020 Q4
FY 2021 Q2$2,550M; −6.2% vs FY 2021 Q1
FY 2021 Q3$2,774M; +8.8% vs FY 2021 Q2
FY 2021 Q4$2,744M; −1.1% vs FY 2021 Q3
FY 2022 Q1$2,611M; −4.8% vs FY 2021 Q4
FY 2022 Q2$2,453M; −6.1% vs FY 2022 Q1
FY 2022 Q3$2,486M; +1.3% vs FY 2022 Q2
FY 2022 Q4$2,333M; −6.2% vs FY 2022 Q3
FY 2023 Q1$2,331M; −0.1% vs FY 2022 Q4
FY 2023 Q2$2,338M; +0.3% vs FY 2023 Q1
FY 2023 Q3$2,295M; −1.8% vs FY 2023 Q2
FY 2023 Q4$2,288M; −0.3% vs FY 2023 Q3
FY 2024 Q1$2,366M; +3.4% vs FY 2023 Q4
FY 2024 Q2$2,397M; +1.3% vs FY 2024 Q1
FY 2024 Q3$2,488M; +3.8% vs FY 2024 Q2
FY 2024 Q4$2,621M; +5.3% vs FY 2024 Q3
FY 2025 Q1$2,652M; +1.2% vs FY 2024 Q4
FY 2025 Q2$2,761M; +4.1% vs FY 2025 Q1
FY 2025 Q3$2,816M; +2.0% vs FY 2025 Q2
FY 2025 Q4$2,806M; −0.4% vs FY 2025 Q3
FY 2026 Q1$2,895M; +3.2% vs FY 2025 Q4
FY 2026 Q2$3,043M; +5.1% vs FY 2026 Q1
Jun 30, 2009 through Sep 25, 2026

Free cash flow

USD millions

$459M
Quest Diagnostics Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2009 Q2$-45.593M; Change unavailable vs FY 2009 Q1
FY 2009 Q3$332.506M; +829.3% vs FY 2009 Q2
FY 2009 Q4$310.424M; −6.6% vs FY 2009 Q3
FY 2010 Q1$199.452M; −35.7% vs FY 2009 Q4
FY 2010 Q2$160.084M; −19.7% vs FY 2010 Q1
FY 2010 Q3$282.631M; +76.6% vs FY 2010 Q2
FY 2010 Q4$270.48M; −4.3% vs FY 2010 Q3
FY 2011 Q1$121.589M; −55.0% vs FY 2010 Q4
FY 2011 Q2$19.87M; −83.7% vs FY 2011 Q1
FY 2011 Q3$298.39M; +1401.7% vs FY 2011 Q2
FY 2011 Q4$294.069M; −1.4% vs FY 2011 Q3
FY 2012 Q1$131.269M; −55.4% vs FY 2011 Q4
FY 2012 Q2$203.457M; +55.0% vs FY 2012 Q1
FY 2012 Q3$349.711M; +71.9% vs FY 2012 Q2
FY 2012 Q4$320.497M; −8.4% vs FY 2012 Q3
FY 2013 Q1$-1.854M; −100.6% vs FY 2012 Q4
FY 2013 Q2$152.46M; +8323.3% vs FY 2013 Q1
FY 2013 Q3$135.575M; −11.1% vs FY 2013 Q2
FY 2013 Q4$134.819M; −0.6% vs FY 2013 Q3
FY 2014 Q1$16M; −88.1% vs FY 2013 Q4
FY 2014 Q2$231M; +1343.8% vs FY 2014 Q1
FY 2014 Q3$169M; −26.8% vs FY 2014 Q2
FY 2014 Q4$214M; +26.6% vs FY 2014 Q3
FY 2015 Q1$-4M; −101.9% vs FY 2014 Q4
FY 2015 Q2$214M; +5450.0% vs FY 2015 Q1
FY 2015 Q3$160M; −25.2% vs FY 2015 Q2
FY 2015 Q4$177M; +10.6% vs FY 2015 Q3
FY 2016 Q1$96M; −45.8% vs FY 2015 Q4
FY 2016 Q2$264M; +175.0% vs FY 2016 Q1
FY 2016 Q3$240M; −9.1% vs FY 2016 Q2
FY 2016 Q4$176M; −26.7% vs FY 2016 Q3
FY 2017 Q1$154M; −12.5% vs FY 2016 Q4
FY 2017 Q2$229M; +48.7% vs FY 2017 Q1
FY 2017 Q3$299M; +30.6% vs FY 2017 Q2
FY 2017 Q4$241M; −19.4% vs FY 2017 Q3
FY 2018 Q1$107M; −55.6% vs FY 2017 Q4
FY 2018 Q2$245M; +129.0% vs FY 2018 Q1
FY 2018 Q3$321M; +31.0% vs FY 2018 Q2
FY 2018 Q4$144M; −55.1% vs FY 2018 Q3
FY 2019 Q1$228M; +58.3% vs FY 2018 Q4
FY 2019 Q2$236M; +3.5% vs FY 2019 Q1
FY 2019 Q3$203M; −14.0% vs FY 2019 Q2
FY 2019 Q4$176M; −13.3% vs FY 2019 Q3
FY 2020 Q1$164M; −6.8% vs FY 2019 Q4
FY 2020 Q2$273M; +66.5% vs FY 2020 Q1
FY 2020 Q3$771M; +182.4% vs FY 2020 Q2
FY 2020 Q4$379M; −50.8% vs FY 2020 Q3
FY 2021 Q1$645M; +70.2% vs FY 2020 Q4
FY 2021 Q2$376M; −41.7% vs FY 2021 Q1
FY 2021 Q3$472M; +25.5% vs FY 2021 Q2
FY 2021 Q4$337M; −28.6% vs FY 2021 Q3
FY 2022 Q1$417M; +23.7% vs FY 2021 Q4
FY 2022 Q2$326M; −21.8% vs FY 2022 Q1
FY 2022 Q3$384M; +17.8% vs FY 2022 Q2
FY 2022 Q4$187M; −51.3% vs FY 2022 Q3
FY 2023 Q1$-33M; −117.6% vs FY 2022 Q4
FY 2023 Q2$340M; +1130.3% vs FY 2023 Q1
FY 2023 Q3$102M; −70.0% vs FY 2023 Q2
FY 2023 Q4$455M; +346.1% vs FY 2023 Q3
FY 2024 Q1$50M; −89.0% vs FY 2023 Q4
FY 2024 Q2$268M; +436.0% vs FY 2024 Q1
FY 2024 Q3$250M; −6.7% vs FY 2024 Q2
FY 2024 Q4$341M; +36.4% vs FY 2024 Q3
FY 2025 Q1$197M; −42.2% vs FY 2024 Q4
FY 2025 Q2$436M; +121.3% vs FY 2025 Q1
FY 2025 Q3$419M; −3.9% vs FY 2025 Q2
FY 2025 Q4$307M; −26.7% vs FY 2025 Q3
FY 2026 Q1$164M; −46.6% vs FY 2025 Q4
FY 2026 Q2$459M; +179.9% vs FY 2026 Q1

Net margin

%

10.52%
Quest Diagnostics Net margin. Reported fiscal history.
Fiscal period%
FY 2009 Q29.9%
FY 2009 Q310.13%
FY 2009 Q49.82%
FY 2010 Q19%
FY 2010 Q210.38%
FY 2010 Q310.62%
FY 2010 Q49.09%
FY 2011 Q1-2.96%
FY 2011 Q28.57%
FY 2011 Q39.01%
FY 2011 Q410.08%
FY 2012 Q18.22%
FY 2012 Q29.32%
FY 2012 Q38.81%
FY 2012 Q43.15%
FY 2013 Q17.6%
FY 2013 Q29.11%
FY 2013 Q322.67%
FY 2013 Q48.14%
FY 2014 Q15.96%
FY 2014 Q26.99%
FY 2014 Q36.78%
FY 2014 Q410.09%
FY 2015 Q13.32%
FY 2015 Q26.13%
FY 2015 Q318.19%
FY 2015 Q410.17%
FY 2016 Q15.48%
FY 2016 Q210.23%
FY 2016 Q310.19%
FY 2016 Q48.33%
FY 2017 Q18.64%
FY 2017 Q29.93%
FY 2017 Q38.34%
FY 2017 Q413.12%
FY 2018 Q19.39%
FY 2018 Q211.41%
FY 2018 Q311.28%
FY 2018 Q46.91%
FY 2019 Q18.67%
FY 2019 Q211.57%
FY 2019 Q310.99%
FY 2019 Q413.14%
FY 2020 Q15.43%
FY 2020 Q210.13%
FY 2020 Q320.39%
FY 2020 Q419.29%
FY 2021 Q117.24%
FY 2021 Q224.75%
FY 2021 Q318.2%
FY 2021 Q414.21%
FY 2022 Q113.6%
FY 2022 Q29.54%
FY 2022 Q310.3%
FY 2022 Q44.33%
FY 2023 Q18.67%
FY 2023 Q210.05%
FY 2023 Q39.8%
FY 2023 Q48.39%
FY 2024 Q18.2%
FY 2024 Q29.55%
FY 2024 Q39.08%
FY 2024 Q48.47%
FY 2025 Q18.3%
FY 2025 Q210.21%
FY 2025 Q38.7%
FY 2025 Q48.73%
FY 2026 Q18.7%
FY 2026 Q210.52%

P/E

× · TTM · Daily

24.92×
Quest Diagnostics P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2011-02-2813.53×2010-12-31
2011-03-3113.76×2010-12-31
2011-04-2913.44×2010-12-31
2011-05-3118.7×2011-03-31
2011-06-3018.91×2011-03-31
2011-07-2918.19×2011-06-30
2011-08-3116.86×2011-06-30
2011-09-3016.63×2011-06-30
2011-10-3118.79×2011-06-30
2011-11-3020.87×2011-09-30
2011-12-3020.66×2011-09-30
2012-01-3120.66×2011-09-30
2012-02-2920.65×2011-09-30
2012-03-3021.76×2011-09-30
2012-04-3013.48×2012-03-31
2012-05-3113.29×2012-03-31
2012-06-2914×2012-03-31
2012-07-3113.37×2012-06-30
2012-08-3113.84×2012-06-30
2012-09-2814.52×2012-06-30
2012-10-3113.46×2012-09-30
2012-11-3013.47×2012-09-30
2012-12-3113.58×2012-09-30
2013-01-3113.51×2012-09-30
2013-02-2816.18×2012-12-31
2013-03-2816.26×2012-12-31
2013-04-3016.87×2013-03-31
2013-05-3118.52×2013-03-31
2013-06-2818.15×2013-03-31
2013-07-3117.27×2013-06-30
2013-08-3017.36×2013-06-30
2013-09-3018.3×2013-06-30
2013-10-3111.86×2013-09-30
2013-11-2912.07×2013-09-30
2013-12-3110.6×2013-09-30
2014-01-3110.4×2013-09-30
2014-02-2810.49×2013-09-30
2014-03-3111.47×2013-09-30
2014-04-3011.07×2013-09-30
2014-05-3011.86×2013-09-30
2014-06-3011.62×2013-09-30
2014-07-3112.1×2013-09-30
2014-08-2912.52×2013-09-30
2014-09-3012.01×2013-09-30
2014-10-3112.57×2013-09-30
2014-11-2812.93×2013-09-30
2014-12-3113.28×2013-09-30
2015-01-3014.07×2013-09-30
2015-02-2713.89×2013-09-30
2015-03-3115.22×2013-09-30
2015-04-3014.14×2013-09-30
2015-05-2914.9×2013-09-30
2015-06-3014.36×2013-09-30
2015-07-3114.61×2013-09-30
2015-08-3113.42×2013-09-30
2015-09-3012.17×2013-09-30
2015-10-3013.45×2013-09-30
2015-11-3013.53×2013-09-30
2015-12-3114.09×2013-09-30
2016-01-2913×2013-09-30
2016-02-2913.61×2015-12-31
2016-03-3114.61×2015-12-31
2016-04-2914.43×2016-03-31
2016-05-3114.82×2016-03-31
2016-06-3015.63×2016-03-31
2016-07-2914.85×2016-06-30
2016-08-3114.24×2016-06-30
2016-09-3014.55×2016-06-30
2016-10-3117.16×2016-09-30
2016-11-3018.43×2016-09-30
2016-12-3019.36×2016-09-30
2017-01-3119.37×2016-09-30
2017-02-2821.1×2016-12-31
2017-03-3121.26×2016-12-31
2017-04-2821.19×2017-03-31
2017-05-3121.85×2017-03-31
2017-06-3022.33×2017-03-31
2017-07-3121.63×2017-06-30
2017-08-3121.64×2017-06-30
2017-09-2918.7×2017-06-30
2017-10-3119.57×2017-09-30
2017-11-3020.54×2017-09-30
2017-12-2920.55×2017-09-30
2018-01-3122.08×2017-09-30
2018-02-2818.76×2017-12-31
2018-03-2918.26×2017-12-31
2018-04-3017.97×2018-03-31
2018-05-3118.91×2018-03-31
2018-06-2919.52×2018-03-31
2018-07-3118.51×2018-06-30
2018-08-3118.9×2018-06-30
2018-09-2818.54×2018-06-30
2018-10-3115.19×2018-09-30
2018-11-3014.3×2018-09-30
2018-12-3113.44×2018-09-30
2019-01-3114.1×2018-09-30
2019-02-2816.41×2018-12-31
2019-03-2917.05×2018-12-31
2019-04-3018.28×2018-12-31
2019-05-3118.19×2018-12-31
2019-06-2819.31×2018-12-31
2019-07-3119.36×2018-12-31
2019-08-3019.41×2018-12-31
2019-09-3020.3×2018-12-31
2019-10-3119.2×2018-12-31
2019-11-2920.21×2018-12-31
2019-12-3120.25×2018-12-31
2020-01-3120.99×2018-12-31
2020-02-2816.81×2019-12-31
2020-03-3112.73×2019-12-31
2020-04-3017.45×2019-12-31
2020-05-2920.14×2020-03-31
2020-06-3019.4×2020-03-31
2020-07-3122.98×2020-06-30
2020-08-3120.12×2020-06-30
2020-09-3020.71×2020-06-30
2020-10-3015.14×2020-09-30
2020-11-3015.37×2020-09-30
2020-12-3114.77×2020-09-30
2021-01-2916.01×2020-09-30
2021-02-2610.99×2020-12-31
2021-03-3112.2×2020-12-31
2021-04-309.89×2021-03-31
2021-05-289.87×2021-03-31
2021-06-309.89×2021-03-31
2021-07-308.01×2021-06-30
2021-08-318.64×2021-06-30
2021-09-308.21×2021-06-30
2021-10-298.4×2021-09-30
2021-11-308.51×2021-09-30
2021-12-319.9×2021-09-30
2022-01-317.73×2021-09-30
2022-02-287.51×2021-09-30
2022-03-318.58×2021-12-31
2022-04-298.61×2022-03-31
2022-05-319.07×2022-03-31
2022-06-308.55×2022-03-31
2022-07-2910.95×2022-06-30
2022-08-3110.05×2022-06-30
2022-09-309.84×2022-06-30
2022-10-3113.73×2022-09-30
2022-11-3014.51×2022-09-30
2022-12-3014.95×2022-09-30
2023-01-3114.19×2022-09-30
2023-02-2816.82×2022-12-31
2023-03-3117.2×2022-12-31
2023-04-2816.88×2022-12-31
2023-05-3118.9×2023-03-31
2023-06-3020.03×2023-03-31
2023-07-3119.41×2023-06-30
2023-08-3118.88×2023-06-30
2023-09-2917.5×2023-06-30
2023-10-3119.44×2023-09-30
2023-11-3020.5×2023-09-30
2023-12-2920.6×2023-09-30
2024-01-3119.19×2023-09-30
2024-02-2916.09×2023-12-31
2024-03-2817.15×2023-12-31
2024-04-3018.29×2024-03-31
2024-05-3118.8×2024-03-31
2024-06-2818.12×2024-03-31
2024-07-3118.97×2024-06-30
2024-08-3020.93×2024-06-30
2024-09-3020.7×2024-06-30
2024-10-3120.8×2024-09-30
2024-11-2921.86×2024-09-30
2024-12-3120.27×2024-09-30
2025-01-3121.91×2024-09-30
2025-02-2823.02×2024-12-31
2025-03-3122.53×2024-12-31
2025-04-3022.45×2025-03-31
2025-05-3021.84×2025-03-31
2025-06-3022.63×2025-03-31
2025-07-3119.91×2025-06-30
2025-08-2921.61×2025-06-30
2025-09-3022.67×2025-06-30
2025-10-3120.52×2025-09-30
2025-11-2822.06×2025-09-30
2025-12-3120.24×2025-09-30
2026-01-3021.81×2025-09-30
2026-02-2724.14×2025-12-31
2026-03-3122.32×2025-12-31
2026-04-3021.24×2026-03-31
2026-05-2921.32×2026-03-31
2026-06-3023.18×2026-03-31
2026-07-3124.57×2026-06-30
2026-08-3125.34×2026-06-30
2026-09-2524.92×2026-06-30
Mean 16.63×Median 17.29×44% above median

ROIC

% · Annual / TTM

9.89%
Quest Diagnostics ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2009 Q2—
FY 2009 Q3—
FY 2009 Q4—
FY 2010 Q1—
FY 2010 Q212.58%
FY 2010 Q312.77%
FY 2010 Q412.6%
FY 2011 Q19.36%
FY 2011 Q28.15%
FY 2011 Q37.83%
FY 2011 Q48.32%
FY 2012 Q111.49%
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q410.1%
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q412.77%
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q48.92%
FY 2015 Q19.91%
FY 2015 Q210.37%
FY 2015 Q312.66%
FY 2015 Q411.48%
FY 2016 Q111.47%
FY 2016 Q212.11%
FY 2016 Q39.97%
FY 2016 Q49.5%
FY 2017 Q19.8%
FY 2017 Q29.87%
FY 2017 Q39.53%
FY 2017 Q410.73%
FY 2018 Q110.84%
FY 2018 Q211.23%
FY 2018 Q311.88%
FY 2018 Q410.04%
FY 2019 Q19.64%
FY 2019 Q29.31%
FY 2019 Q39.24%
FY 2019 Q410.37%
FY 2020 Q19.67%
FY 2020 Q29.32%
FY 2020 Q312.65%
FY 2020 Q415.74%
FY 2021 Q119.54%
FY 2021 Q221.92%
FY 2021 Q321.38%
FY 2021 Q419.02%
FY 2022 Q117.9%
FY 2022 Q216.79%
FY 2022 Q314.73%
FY 2022 Q411.68%
FY 2023 Q19.89%
FY 2023 Q29.32%
FY 2023 Q38.94%
FY 2023 Q49.87%
FY 2024 Q19.49%
FY 2024 Q29.25%
FY 2024 Q38.53%
FY 2024 Q49.04%
FY 2025 Q19.25%
FY 2025 Q29.69%
FY 2025 Q39.43%
FY 2025 Q49.51%
FY 2026 Q19.58%
FY 2026 Q29.89%

Capital allocation

% of tracked cash uses

$734M
Quest Diagnostics capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q277.4% · $36.386M22.6% · $10.623MUnavailableUnavailableUnavailable100% · $47.009M
FY 2009 Q390.02% · $41.037M9.98% · $4.551MUnavailableUnavailableUnavailable100% · $45.588M
FY 2009 Q44.83% · $49.895M0.16% · $1.692M82.32% · $849.982M12.68% · $130.974MUnavailable100% · $1,032.543M
FY 2010 Q112.87% · $39.763M0% · $0M81.18% · $250.712M5.95% · $18.372MUnavailable100% · $308.847M
FY 2010 Q220.27% · $49.085M0% · $0M72.28% · $175.061M7.46% · $18.058MUnavailable100% · $242.204M
FY 2010 Q312.18% · $47.443M0% · $0M83.25% · $324.227M4.57% · $17.787MUnavailable100% · $389.457M
FY 2010 Q426.76% · $69.109M0% · $0M0% · $0M6.62% · $17.104M66.62% · $172.069M100% · $258.282M
FY 2011 Q12.66% · $38.991MUnavailable56.88% · $835.001M1.17% · $17.136M39.3% · $576.891M100% · $1,468.019M
FY 2011 Q23.33% · $39.633M95.35% · $1,136.38M0% · $0M1.33% · $15.794MUnavailable100% · $1,191.807M
FY 2011 Q314.69% · $39.255M60.66% · $162.138M18.7% · $49.994M5.95% · $15.9MUnavailable100% · $267.287M
FY 2011 Q439.85% · $43.677M0.1% · $0.106M45.61% · $49.999M14.44% · $15.832MUnavailable100% · $109.614M
FY 2012 Q14.8% · $29.998M8.09% · $50.556M8% · $50M4.31% · $26.9M74.8% · $467.312M100% · $624.766M
FY 2012 Q28.51% · $47.41M0% · $0.012M8.98% · $50M4.86% · $27.081M77.64% · $432.334M100% · $556.837M
FY 2012 Q310.11% · $44.91M0% · $0.006M11.25% · $49.996M6.09% · $27.053M72.55% · $322.39M100% · $444.355M
FY 2012 Q421.07% · $59.916M0% · $0M17.58% · $50M9.53% · $27.102M51.82% · $147.374M100% · $284.392M
FY 2013 Q112.88% · $49.097M23.71% · $90.393M16.17% · $61.63M12.51% · $47.695M34.73% · $132.394M100% · $381.209M
FY 2013 Q26.01% · $55.621M9.68% · $89.556M48.64% · $450M5.14% · $47.572M30.52% · $282.398M100% · $925.147M
FY 2013 Q35.51% · $50.749MUnavailable52.36% · $482.472M4.96% · $45.734M37.17% · $342.442M100% · $921.397M
FY 2013 Q422.33% · $75.533M9.79% · $33.105M12.68% · $42.898M13.01% · $43.999M42.2% · $142.766M100% · $338.301M
FY 2014 Q14.16% · $68M34.72% · $567M1.96% · $32M2.63% · $43M56.52% · $923M100% · $1,633M
FY 2014 Q29.53% · $49M30.35% · $156M4.86% · $25M9.34% · $48M45.91% · $236M100% · $514M
FY 2014 Q321.07% · $102M0.41% · $2M5.17% · $25M9.92% · $48M63.43% · $307M100% · $484M
FY 2014 Q423.99% · $89M0.81% · $3M13.48% · $50M12.94% · $48M48.79% · $181M100% · $371M
FY 2015 Q18.56% · $56M0% · $0M16.82% · $110M7.34% · $48M67.28% · $440M100% · $654M
FY 2015 Q23.96% · $61M0.39% · $6M2.53% · $39M3.57% · $55M89.56% · $1,381M100% · $1,542M
FY 2015 Q38.95% · $52M6.02% · $35M4.3% · $25M9.47% · $55M71.26% · $414M100% · $581M
FY 2015 Q417.87% · $94M4.94% · $26M9.51% · $50M10.27% · $54M57.41% · $302M100% · $526M
FY 2016 Q15.84% · $47M16.77% · $135M14.29% · $115M6.83% · $55M56.27% · $453M100% · $805M
FY 2016 Q23.44% · $57M0% · $0M16.62% · $275M3.38% · $56M76.56% · $1,267M100% · $1,655M
FY 2016 Q335.06% · $61M2.3% · $4M28.74% · $50M32.76% · $57M1.15% · $2M100% · $174M
FY 2016 Q438.21% · $128M0% · $0M44.78% · $150M16.42% · $55M0.6% · $2M100% · $335M
FY 2017 Q116.34% · $42M0.39% · $1M58.37% · $150M24.12% · $62M0.78% · $2M100% · $257M
FY 2017 Q216.71% · $65M28.53% · $111M38.56% · $150M15.94% · $62M0.26% · $1M100% · $389M
FY 2017 Q317.31% · $63M51.37% · $187M13.74% · $50M17.03% · $62M0.55% · $2M100% · $364M
FY 2017 Q411.44% · $82M39.33% · $282M16.04% · $115M8.51% · $61M24.69% · $177M100% · $717M
FY 2018 Q16.37% · $73M11.34% · $130M4.36% · $50M5.32% · $61M72.6% · $832M100% · $1,146M
FY 2018 Q28.65% · $78M3.88% · $35M0% · $0M7.54% · $68M79.93% · $721M100% · $902M
FY 2018 Q319.47% · $81M12.98% · $54M24.04% · $100M16.59% · $69M26.92% · $112M100% · $416M
FY 2018 Q416.89% · $151M22.6% · $202M19.24% · $172M7.61% · $68M33.67% · $301M100% · $894M
FY 2019 Q14.56% · $47M5.44% · $56M5.15% · $53M6.99% · $72M77.86% · $802M100% · $1,030M
FY 2019 Q29.98% · $85M0% · $0M5.87% · $50M8.33% · $71M75.82% · $646M100% · $852M
FY 2019 Q344.04% · $96M0% · $0M22.94% · $50M33.03% · $72M0% · $0M100% · $218M
FY 2019 Q438.57% · $172M0.45% · $2M44.84% · $200M15.92% · $71M0.22% · $1M100% · $446M
FY 2020 Q17.29% · $83M9.49% · $108M6.59% · $75M6.24% · $71M70.39% · $801M100% · $1,138M
FY 2020 Q217.19% · $82M25.16% · $120M0% · $0M15.72% · $75M41.93% · $200M100% · $477M
FY 2020 Q333.83% · $91M37.55% · $101M0% · $0M28.25% · $76M0.37% · $1M100% · $269M
FY 2020 Q415.58% · $162M0.1% · $1M24.04% · $250M7.21% · $75M53.08% · $552M100% · $1,040M
FY 2021 Q115.03% · $86M0% · $0M71.68% · $410M13.11% · $75M0.17% · $1M100% · $572M
FY 2021 Q24.43% · $84M12.18% · $231M79.11% · $1,500M4.27% · $81M0% · $0M100% · $1,896M
FY 2021 Q347.85% · $89M10.75% · $20M0% · $0M40.86% · $76M0.54% · $1M100% · $186M
FY 2021 Q424.41% · $144M13.56% · $80M48.98% · $289M13.05% · $77M0% · $0M100% · $590M
FY 2022 Q110.23% · $63M17.05% · $105M60.55% · $373M12.01% · $74M0.16% · $1M100% · $616M
FY 2022 Q221.41% · $76M0.28% · $1M56.34% · $200M21.97% · $78M0% · $0M100% · $355M
FY 2022 Q320.7% · $118M0% · $0M65.61% · $374M13.68% · $78M0% · $0M100% · $570M
FY 2022 Q420.36% · $147M5.26% · $38M63.85% · $461M10.39% · $75M0.14% · $1M100% · $722M
FY 2023 Q134.14% · $127M8.33% · $31M0% · $0M19.89% · $74M37.63% · $140M100% · $372M
FY 2023 Q27.17% · $104M39.86% · $578M0% · $0M5.52% · $80M47.45% · $688M100% · $1,450M
FY 2023 Q313.38% · $105M0.25% · $2M0% · $0M10.19% · $80M76.18% · $598M100% · $785M
FY 2023 Q48.52% · $72M0% · $0M32.54% · $275M9.47% · $80M49.47% · $418M100% · $845M
FY 2024 Q132% · $104M43.69% · $142MUnavailable24.31% · $79M0% · $0M100% · $325M
FY 2024 Q215.78% · $92M18.18% · $106MUnavailable14.41% · $84M51.63% · $301M100% · $583M
FY 2024 Q36.15% · $106M88.92% · $1,533MUnavailable4.87% · $84M0.06% · $1M100% · $1,724M
FY 2024 Q416.58% · $123M51.62% · $383M20.35% · $151M11.32% · $84M0.13% · $1M100% · $742M
FY 2025 Q114.61% · $117M0% · $0MUnavailable10.49% · $84M74.91% · $600M100% · $801M
FY 2025 Q217.53% · $108M2.76% · $17MUnavailable14.61% · $90M65.1% · $401M100% · $616M
FY 2025 Q333.72% · $144M7.96% · $34M35.13% · $150M20.84% · $89M2.34% · $10M100% · $427M
FY 2025 Q426.38% · $158M8.35% · $50M50.08% · $300M15.03% · $90M0.17% · $1M100% · $599M
FY 2026 Q147.3% · $114M15.77% · $38MUnavailable36.51% · $88M0.41% · $1M100% · $241M
FY 2026 Q218.8% · $138M0% · $0MUnavailable13.08% · $96M68.12% · $500M100% · $734M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Quest Diagnostics.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources